37 results
ARS
2023 FY
TARS
Tarsus Pharmaceuticals Inc
26 Apr 24
Annual report to shareholders
4:27pm
, our third-party supply chain providers, their facilities and XDEMVY used in our clinical trials or for commercial sale are required to be in compliance … and manufacture of XDEMVY to assess compliance with applicable regulations. Our failure, or the failure of our third-party providers and supply chain providers
8-K
EX-99.1
2c0i0 r3tkq
10 Aug 23
Tarsus Reports Second Quarter 2023 Financial Results and Recent Business Achievements
4:07pm
8-K
EX-99.1
8oh9yjx8n6mxojww
9 May 23
Tarsus Reports First Quarter 2023 Financial Results and Recent Business Achievements
4:07pm
ARS
sjlqox9 tmk
26 Apr 23
Annual report to shareholders
4:08pm
8-K
EX-99.1
xmcrpy53kw5
8 Nov 22
Tarsus Reports Third Quarter 2022 Financial Results and Recent Business Achievements
9:50pm
8-K
EX-99.1
162kno357 3e
11 Aug 22
Tarsus Reports Second Quarter 2022 Financial Results and Recent Business Achievements
4:09pm
8-K
EX-99.1
y3wjy hvwg6bux5r2h
10 May 22
Tarsus Reports First Quarter 2022 Financial Results and Recent Business Achievements
4:16pm
8-K
ag064hjgie7a
3 May 22
Other Events
7:09am
FWP
en26ex2iig
3 May 22
Free writing prospectus
6:16am
8-K
EX-99.1
aebd4lm zr
14 Mar 22
Tarsus Pharmaceuticals, Inc. Reports Full-Year 2021 Financial Results and Recent Business Achievements
4:14pm